347 related articles for article (PubMed ID: 16377139)
1. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
Privitera M
Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139
[TBL] [Abstract][Full Text] [Related]
2. NIH epilepsy branch trials: budgetary and practical issues.
Jacobs MP
Epilepsy Res Suppl; 1993; 10():239-44. PubMed ID: 8251102
[No Abstract] [Full Text] [Related]
3. The Antiepileptic Drug Development Program: an example of government-industry collaboration.
White BG
Prog Clin Biol Res; 1985; 197():83-93. PubMed ID: 4070302
[TBL] [Abstract][Full Text] [Related]
4. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
5. Industry sponsorship and selection of comparators in randomized clinical trials.
Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP
Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879
[TBL] [Abstract][Full Text] [Related]
6. Advisors may urge NIH to seek out industry support for clinical trials.
Appel A
Nature; 1995 Nov; 378(6553):116. PubMed ID: 7477301
[No Abstract] [Full Text] [Related]
7. Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients.
Chadwick D; Marson T
Epilepsia; 2007 Jul; 48(7):1259-63. PubMed ID: 17442006
[TBL] [Abstract][Full Text] [Related]
8. AIDS research. Drug trials without the drugs?
Cohen J
Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159
[No Abstract] [Full Text] [Related]
9. NIH urged to cap profits made on publicly funded research.
Macilwain C
Nature; 2000 Jul; 406(6791):5. PubMed ID: 10894508
[No Abstract] [Full Text] [Related]
10. Biomedical research funding: when the game gets tough, winners start to play.
Ascoli GA
Bioessays; 2007 Sep; 29(9):933-6. PubMed ID: 17688241
[TBL] [Abstract][Full Text] [Related]
11. The NIH, research institutions and industry: working together on a shared goal.
Omary MB
Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
[No Abstract] [Full Text] [Related]
12. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
Lachin JM
Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
[TBL] [Abstract][Full Text] [Related]
13. Ethics. Senate probe of research psychiatrists.
Kaiser J
Science; 2009 Jul; 325(5936):30. PubMed ID: 19574367
[No Abstract] [Full Text] [Related]
14. Comparative effectiveness casts first shadows across US industry.
Waltz E
Nat Biotechnol; 2009 Mar; 27(3):211-2. PubMed ID: 19270651
[No Abstract] [Full Text] [Related]
15. NIH common fund concerns some in cancer research community.
Vanchieri C
J Natl Cancer Inst; 2007 Mar; 99(5):345. PubMed ID: 17341723
[No Abstract] [Full Text] [Related]
16. Barriers to clinical trial enrollment: are state mandates the solution?
Hillner BE
J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
[No Abstract] [Full Text] [Related]
17. Protecting an endangered species: training physicians to conduct clinical research.
Goldhamer ME; Cohen AP; Bates DW; Cook EF; Davis RB; Singer DE; Simon SR
Acad Med; 2009 Apr; 84(4):439-45. PubMed ID: 19318774
[TBL] [Abstract][Full Text] [Related]
18. NIH funding: what does the future look like?
Avantaggiati ML
Science; 2007 Apr; 316(5822):198-200; author reply 198-200. PubMed ID: 17436448
[No Abstract] [Full Text] [Related]
19. NIH funding: what does the future look like?
Furcht LT
Science; 2007 Apr; 316(5822):198-200; author reply 198-200. PubMed ID: 17431152
[No Abstract] [Full Text] [Related]
20. NIH funding: what does the future look like?
Werner MH
Science; 2007 Apr; 316(5822):198-200; author reply 198-200. PubMed ID: 17436447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
